Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Details | |
|---|---|---|---|---|
Traws Pharma, Inc.Listing on record | AwardD (derivative) | — | SEC | |
Traws Pharma, Inc.Listing on record | AwardD (derivative) | — | SEC | |
Traws Pharma, Inc.Listing on record | AwardD (derivative) | — | SEC | |
Traws Pharma, Inc.Listing on record | Award | — | SEC | |
Traws Pharma, Inc.Listing on record | AwardD (derivative) | — | SEC | |
Traws Pharma, Inc.Listing on record | AwardD (derivative) | — | SEC | |
IPI Legacy Liquidation CoListing unverified | AwardD (derivative) | — | SEC | |
IPI Legacy Liquidation CoListing unverified | Other | $13.6K | SEC | |
IPI Legacy Liquidation CoListing unverified | ExerciseD (derivative) | — | SEC | |
IPI Legacy Liquidation CoListing unverified | Exercise | — | SEC | |
IPI Legacy Liquidation CoListing unverified | AwardD (derivative) | — | SEC | |
IPI Legacy Liquidation CoListing unverified | AwardD (derivative) | — | SEC | |
IPI Legacy Liquidation CoListing unverified | AwardD (derivative) | — | SEC | |
Cartesian Therapeutics, Inc.Listing on record | AwardD (derivative) | — | SEC | |
Cartesian Therapeutics, Inc.Listing on record | AwardD (derivative) | — | SEC | |
Aevi Genomic Medicine, LLCListing unverified | AwardD (derivative) | — | SEC | |
Aevi Genomic Medicine, LLCListing unverified | AwardD (derivative) | $55.4K | SEC | |
Aevi Genomic Medicine, LLCListing unverified | AwardD (derivative) | — | SEC |